CJC-1295 DAC Product Specifications:

CJC-1295 DAC, a synthetic peptide, mimics growth hormone-releasing hormone (GHRH). Scientists craft it with 29 amino acids, enhancing its stability. Consequently, it includes a drug affinity complex (DAC) for prolonged activity. Moreover, its design resists rapid breakdown in the body. Thus, it fascinates researchers in peptide science.

The peptide binds selectively to GHRH receptors, showing high affinity. Furthermore, it incorporates a lysine linker in the DAC component. As a result, scientists study CJC-1295 DAC’s molecular interactions closely. Additionally, its production employs solid-phase peptide synthesis. Hence, researchers investigate its manufacturing process.

Development in the early 2000s marked a breakthrough. Initially, ConjuChem, a Canadian biotech firm, engineered it. Subsequently, its name reflects its chemical structure and DAC addition. Moreover, it sparks interest in biochemical studies worldwide. Therefore, it drives innovative experiments.

In research, CJC-1295 DAC circulates effectively in experimental models. Furthermore, it maintains stability under physiological conditions. Consequently, scientists explore its pharmacokinetic properties. Additionally, labs globally analyze its structural traits. Thus, this peptide fuels advancements in research, encouraging deeper scientific inquiry.

• Appearance:Solid white powder in 3ml glass vial
• Chemical Formula:C152H252N44O42
• PubChem CID:91976842
• CAS Number:446262-90-4
• Molecular Weight:3647.954 g/mol
• Storage:Store in a cool, dry place away from light, heat and moisture
• Synonyms:CJC-1295-DAC
• Sequence:Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-DAC
• Concentration:≥98%